|
Acta Biomaterialia
|
2 |
2.00 |
|
|
|
American Journal of Clinical Nutrition
|
1 |
0.83 |
|
|
|
American Journal of Obstetrics and Gynecology
|
1 |
1.00 |
|
|
|
American Journal of Respiratory and Critical Care Medicine
|
8 |
4.14 |
|
|
|
Analytical Chemistry
|
3 |
0.25 |
|
|
|
Anesthesiology
|
4 |
2.38 |
|
|
|
Annals of Internal Medicine
|
2 |
1.07 |
|
|
|
Annals of Neurology
|
2 |
0.36 |
|
|
|
Annals of Surgery
|
6 |
2.25 |
|
|
|
Annals of the Rheumatic Diseases
|
18 |
4.93 |
|
Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial
|
0.08 |
|
Musculoskeletal ultrasound findings in people with asymptomatic hyperuricemia: baseline analysis from the Transitions in Gout Research (TIGER) study using the OMERACT gout ultrasound semiquantitative scoring system
|
0.04 |
|
Psoriatic arthritis monocyte DNA methylomes bridge joint and skin inflammatory pathways across rheumatoid arthritis and psoriasis
|
0.04 |
|
Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score
|
0.20 |
|
Prevalence and impact of suspected fibromyalgia on disease outcomes and treatment in axial spondyloarthritis: 10-year follow-up data from the DESIR cohort
|
0.80 |
|
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis
|
0.07 |
|
The positive perspective paradigm: proposal of a model to mitigate the impact of chronic inflammatory arthritis through comprehensive and early intervention
|
0.14 |
|
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)
|
0.06 |
|
A genetic variant of BAFF is associated with the risk of lymphoma in Sjögren disease
|
0.80 |
|
Evaluation of the placebo and treatment effect overtime in randomised clinical trials evaluating the efficacy of biologics in axial spondyloarthritis: systematic review and meta-analysis
|
1.00 |
|
A de novo dominant-negative PSMB8 mutation causes severe CANDLE/PRAAS due to arrested proteasome biogenesis
|
0.14 |
|
Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of life
|
0.38 |
|
Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44)
|
0.14 |
|
Spatial mapping of rheumatoid arthritis synovial niches reveals a LYVE1+ macrophage network associated with response to therapy
|
0.73 |
|
Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland
|
0.05 |
|
Genome-wide association study in chondrocalcinosis reveals ENPP1 as a candidate therapeutic target in calcium pyrophosphate deposition disease
|
0.13 |
|
Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial
|
0.07 |
|
Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1
|
0.07 |
|
|
Archives of Physical Medicine and Rehabilitation
|
1 |
1.00 |
|
|
|
Arthritis & Rheumatology
|
13 |
8.17 |
|
|
|
Brain
|
7 |
4.90 |
|
|
|
British Journal of Surgery
|
2 |
0.91 |
|
|
|
Cell
|
2 |
1.11 |
|
|
|
Cell Host & Microbe
|
2 |
0.63 |
|
|
|
Cell Metabolism
|
2 |
0.74 |
|
|
|
Chemical Science
|
1 |
1.00 |
|
|
|
Chest
|
4 |
1.55 |
|
|
|
Circulation
|
2 |
0.07 |
|
|
|
Clinical Infectious Diseases
|
13 |
8.38 |
|
|
|
Critical Care Medicine
|
7 |
3.17 |
|
|
|
Current Biology
|
6 |
4.76 |
|
|
|
Developmental Cell
|
1 |
0.07 |
|
|
|
Diabetes Care
|
2 |
1.10 |
|
|
|
Environmental Health Perspectives
|
1 |
0.09 |
|
|
|
Environmental Pollution
|
4 |
3.08 |
|
|
|
Environmental Research
|
4 |
1.41 |
|
|
|
Environmental Science and Technology
|
2 |
0.13 |
|
|
|
European Heart Journal
|
2 |
0.30 |
|
|
|
European Urology
|
2 |
0.21 |
|
|
|
Gastroenterology
|
1 |
1.00 |
|
|
|
Gut
|
9 |
2.83 |
|
|
|
Hepatology
|
7 |
1.47 |
|
|
|
Human Reproduction
|
2 |
1.10 |
|
|
|
Immunity
|
2 |
0.10 |
|
|
|
Inorganic Chemistry
|
1 |
0.29 |
|
|
|
International Journal of Obesity
|
3 |
1.30 |
|
|
|
JAMA Internal Medicine
|
2 |
0.08 |
|
|
|
JAMA Psychiatry
|
2 |
0.25 |
|
|
|
JAMA Surgery
|
2 |
1.19 |
|
|
|
JAMA: The Journal of the American Medical Association
|
7 |
3.43 |
|
|
|
Journal of Biological Chemistry
|
6 |
3.93 |
|
|
|
Journal of Bone and Joint Surgery-American Volume
|
3 |
1.03 |
|
|
|
Journal of Clinical Endocrinology & Metabolism
|
11 |
6.21 |
|
|
|
Journal of Clinical Investigation
|
2 |
0.22 |
|
|
|
Journal of Clinical Oncology
|
2 |
2.00 |
|
|
|
Journal of Hepatology
|
12 |
2.94 |
|
|
|
Journal of Infectious Diseases
|
11 |
4.22 |
|
|
|
Journal of Neuroscience
|
2 |
1.13 |
|
|
|
Journal of Physiology
|
5 |
2.90 |
|
|
|
Journal of Thoracic and Cardiovascular Surgery
|
2 |
1.07 |
|
|
|
Journal of the American Academy of Dermatology
|
7 |
3.96 |
|
|
|
Journal of the American Chemical Society
|
3 |
2.26 |
|
|
|
Journal of the American College of Cardiology
|
8 |
2.39 |
|
|
|
Journal of the American Society of Nephrology
|
5 |
2.18 |
|
|
|
Journal of the National Cancer Institute
|
5 |
1.24 |
|
|
|
Kidney International
|
8 |
5.05 |
|
|
|
Molecular Psychiatry
|
9 |
3.05 |
|
|
|
Nature
|
9 |
2.56 |
|
|
|
Nature Communications
|
81 |
30.98 |
|
|
|
Nature Genetics
|
1 |
0.00 |
|
|
|
Nature Human Behaviour
|
1 |
0.29 |
|
|
|
Nature Immunology
|
3 |
0.94 |
|
|
|
Nature Medicine
|
9 |
0.41 |
|
|
|
Nature Neuroscience
|
3 |
1.78 |
|
|
|
PLOS Biology
|
8 |
2.86 |
|
|
|
PLOS Genetics
|
2 |
1.83 |
|
|
|
PLOS Medicine
|
1 |
0.18 |
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
|
23 |
8.29 |
|
|
|
Proceedings of the Royal Society B
|
1 |
1.00 |
|
|
|
Radiology
|
3 |
0.87 |
|
|
|
Science
|
4 |
2.39 |
|
|
|
Science Advances
|
9 |
2.11 |
|
|
|
Science Translational Medicine
|
5 |
3.14 |
|
|
|
The BMJ
|
3 |
1.24 |
|
|
|
The ISME Journal: Multidisciplinary Journal of Microbial Ecology
|
2 |
1.30 |
|
|
|
The Journal of Allergy and Clinical Immunology
|
2 |
1.05 |
|
|
|
The Lancet
|
7 |
2.30 |
|
A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial
|
0.07 |
|
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial
|
0.08 |
|
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis
|
0.04 |
|
Cloxacillin versus cefazolin for meticillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a prospective, open-label, multicentre, non-inferiority, randomised clinical trial
|
1.00 |
|
Efficacy and safety of single-anastomosis duodeno-ileal bypass with sleeve gastrectomy versus Roux-en-Y gastric bypass in France (SADISLEEVE): results of a randomised, open-label, superiority trial at 2 years of follow-up
|
1.00 |
|
Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of randomised controlled trials
|
0.06 |
|
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
|
0.06 |
|
|
The Lancet Diabetes & Endocrinology
|
6 |
1.24 |
|
Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised study
|
0.14 |
|
Effect of surgical versus conservative management on cardiovascular outcomes in patients with bilateral adrenal tumours and cortisol excess: an international, retrospective cohort study
|
0.02 |
|
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
|
0.05 |
|
Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis
|
0.14 |
|
Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial
|
0.10 |
|
Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial
|
0.78 |
|
|
The Lancet Global Health
|
5 |
2.12 |
|
|
|
The Lancet Psychiatry
|
3 |
0.18 |
|
|
|
The New England Journal of Medicine
|
14 |
2.00 |
|
|
|
Thorax
|
1 |
1.00 |
|
|
|
Water Research
|
1 |
1.00 |
|
|